Published Articles

Show only items where

Author

Type

Term

Year

Keyword

Export 1 results:

BibTex
XML

Author Title Type [ Year

]

Filters: Keyword is Anti-cancer drug resistance [Clear All Filters]

2022

Alpha-Mangostin Enhances Proliferation in Sorafenib-Surviving HepG2 Liver Cancer Cells by Increasing Anti-Apoptosis and Antioxidant Markers Expressions, Louisa, Melva, Annisa Meuthia Faralita, Basuki Pamela, Lauren Brigitta Cindy, and Adenina Syarinta , Pharmacognosy Journal, June 2022, Volume 14, Issue 3, p.584-590, (2022)

BibTex
XML

PDF (880.51 KB)

Pharmacognosy Journal (Phcog J.) covers different topics in natural product drug discovery, and also publishes manuscripts that describe pharmacognostic investigations, evaluation reports, methods, techniques and applications of all forms of medicinal plant research
Distinctions: The most widely read, cited, and known Pharmacognosy journal and website is well browsed with all the articles published. More than 50,000 readers in nearly every country in the world each month
ISSN : 0975-3575 ; Frequency : Rapid at a time publication (6 issues/year)
Indexed and Abstracted in : SCOPUS, Scimago Journal Ranking, Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Index Copernicus, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
Open Access Journal: Pharmacognosy Journal is an open access journal, which allows authors to fund their article to be open access from publication.

Published Articles

About

Submit your Next Article

Submit your next article to Phcog J

Search form

Published Articles